Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antibody therapies in CNS diseases.
Glial Na(+) -dependent ion transporters in pathophysiological conditions.
Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases.
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: No.
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis.
The Role of Ion Channels in Microglial Activation and Proliferation - A Complex Interplay between Ligand-Gated Ion Channels, K(+) Channels, and Intracellular Ca(2.).
Enhanced mirror activity in 'crossed' reaction time tasks in multiple sclerosis.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
The monoamine oxidase inhibitory activity of essential oils obtained from Eryngium species and their chemical composition.
CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.
Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis.
Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.
[The results of an open prospective study of β-interferon biosimilars (an Yaroslavl' cohort)].
A diffusion tensor imaging atlas of white matter in tree shrew.
Multiple sclerosis in Isfahan, Iran.
Disease onset in familial and sporadic multiple sclerosis in Argentina.
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Pattern and motion-related visual-evoked potentials in neuroborreliosis: follow-up study.
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.
Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia.
Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
Pages
« first
‹ previous
…
685
686
687
688
689
690
691
692
693
…
next ›
last »